When residents begin to take more naps, it might not just be that they are tired. New research indicates it might be an early warning sign of advancing Alzheimer’s disease.
Delayed word processing a possible sign of pending Alzheimer’s
By
John O'Connor
Oct 24, 2017
An inability to process words quickly may be a sign of impending Alzheimer’s disease, British investigators have found.
Benzodiazepines identified as latest Alzheimer’s risk
By
John O'Connor
Aug 16, 2018
Benzodiazepine use may modestly increase the odds your residents will get Alzheimer’s disease, according to a new study.
A very troubling $56 billion question
By
John O'Connor
Jul 08, 2021
Considering some of the alternatives, I’m far from convinced that bankrupting Medicare for the sake of Aduhelm would be money well spent.
Diabetes medications may offset severity of Alzheimer’s
By
John O'Connor
Nov 05, 2018
People with Alzheimer’s disease who were treated with diabetes drugs showed considerably fewer symptoms, Mount Sinai researchers have found.
Blocking a key enzyme may help reverse memory loss
By
John O'Connor
Aug 16, 2017
Interfering with the enzyme that blocks communication between brain cells may help reverse Alzheimer’s-related memory loss, MIT researchers have found.
Statins may help reduce risk for Alzheimer’s disease
By
John O'Connor
Dec 14, 2016
Drugs frequently prescribed to treat high cholesterol might also help reduce the odds a person will suffer from Alzheimer’s disease, a new examination of Medicare data has found.
Hearing loss a possible sign of Alzheimer’s
By
John O'Connor
Dec 14, 2017
Senior living residents who experience age-related hearing loss may be at a higher risk for dementia and cognitive decline, Irish researchers have found.
They must have a chip on their shoulder
By
John O'Connor
Aug 11, 2016
There is a very simple, effective way to prevent residents with dementia from wandering into harm’s way. Unfortunately, it is also illegal in many places.
Combination therapy may be best Alzheimer’s bet, group claims
By
John O'Connor
Dec 13, 2018
Combination therapy likely will yield the most impressive results, according to researchers from the Alzheimer’s Drug Discovery Foundation in New York.